Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep515 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Endocrine-disrupting chemicals and transgenerational inheritance of obesity

Heshmati Hassan

Introduction: Epigenetics is defined as heritable changes in gene expression without changes in the DNA sequence. The transgenerational epigenetic inheritance of diseases is an emerging area of research. Multiple environmental factors including toxicants are associated with the transgenerational inheritance of increased disease susceptibility. Endocrine-disrupting chemicals (EDCs) are a heterogeneous group of exogenous chemicals or chemical mixtures that interfere with the act...

ea0070aep499 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Obesogens and obesity pandemic

Heshmati Hassan

Introduction: Obesity is a worldwide pandemic associated with increased morbidity/mortality and high cost for the society. The prevalence of obesity has doubled in more than 70 countries (including developing countries) since 1980. The number of adult subjects with obesity is around 700 million worldwide. The current pandemic in obesity cannot be explained solely by alterations in food intake and/or decrease in exercise. Obesity pandemic coincides with the marked increase of t...

ea0073aep432 | General Endocrinology | ECE2021

Endocrine function in centenarians

Heshmati Hassan

IntroductionCentenarians are subjects living 100 years or older. They represent a model of successful aging. In 2020, the number of centenarians in the world was approximately 573.000. Multiple endocrine changes occur with normal aging. Most centenarians have managed to avoid, postpone, or overcome the important age-related and life-threatening diseases. The purpose of this review is to present the endocrine function in centenarians with special emphasis...

ea0073aep819 | Late Breaking | ECE2021

The impact of endocrine-disrupting chemicals on the prevalence of diabetes

Heshmati Hassan

IntroductionEndocrine-disrupting chemicals (EDCs) are a heterogeneous group of exogenous chemicals or chemical mixtures that interfere with the action of hormones and cause adverse effects. Humans are constantly exposed to hundreds of EDCs mainly through air, water, and food. Pregnant women are exposed to multiple EDCs that can cross the placenta and enter the fetus. The developing fetus and neonate are more sensitive than adults to perturbation by EDCs....

ea0081ep283 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Pharmacogenomics and efficacy outcome of therapy with glucagon-like peptide-1 receptor agonists in type 2 diabetes

Beniga Camille , Heshmati Hassan

Introduction: Individual variability in drug efficacy and safety due to genetic diversity is a major challenge for clinicians. Pharmacogenetics deals with inherited differences in the efficacy and safety responses to drugs. The incidence of type 2 diabetes (T2D) is increasing worldwide and the disease is reaching pandemic proportions. T2D is treated by oral and/or injectable drugs. The interindividual variability of T2D drug actions may be caused, at least in part, by genetic ...

ea0090ep10 | Adrenal and Cardiovascular Endocrinology | ECE2023

Hair cortisol measurement in the diagnosis and management of adrenal disorders

Abu-Lebdeh Haitham , Heshmati Hassan

Introduction: The acute status of the hypothalamic-pituitary-adrenocortical (HPA) axis is routinely assessed by the measurements of cortisol in blood, saliva, and urine. Because cortisol is continuously deposited in the growing hair shaft, hair cortisol can serve as a practical measure of long-term retrospective HPA axis activity. The purpose of this review is to present the relevance of hair cortisol measurement in the diagnosis and management of Cushing’s syndrome and a...

ea0081p583 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Waist-to-height ratio is a predictor of weight loss with Gelesis200 treatment for people with overweight or obesity having prediabetes or type 2 diabetes in the LIGHT-UP study

Luzi Livio , Greenway Frank , Miller Sam , Matejkova Erika , McLean Barry , Zmuda Witold , Bogdanski Pawel , Arciszewska Malgorzata , Sjodin Anders , Salz Judith , Bochenek-Mularczyk Anna , Lewy-Alterbaum Lorena , Butcher Michael , Paragh Gyorgy , Davis Yvonne , Wilding John , Golub Howard , Leider Harry , Zohar Yishai , Sannino Alessandro , Calderon Henry , Heshmati Hassan

Introduction: Methods to predict clinically meaningful weight loss can help tailor treatment for people with overweight or obesity. LIGHT-UP (NCT03058029), is a multicenter, double-blind, randomized, placebo-controlled study over 25 weeks including 254 people with prediabetes or type 2 diabetes (127 each in the Gelesis200 and placebo arms) with a body mass index between 27 and 40 kg/m2, which demonstrated that Gelesis200 offers a compelling new potential approach in...

ea0063gp139 | Obesity | ECE2019

Prediction of clinically significant weight loss with Gelesis100 in the GLOW study as early as 8 weeks post-treatment

Luzi Livio , Raben Anne , Astrup Arne , Matejkova Erika , Svacina Stepan , Gnessi Lucio , Navas-Carretero Santiago , Martinez J Alfredo , Greenway Frank , Aronne Louis , Apovian Caroline , Kaplan Lee , Hill James , Fujioka Ken , Still Christopher , Sannino Alessandro , Saponaro Cosimo , Calderon Henry , Urban Lorien , Chiquette Elaine , Leider Harry , Ron Eyal , Zohar Yishai , Heshmati Hassan

Introduction: Identification of early responders is widely used in pharmacotherapy for weight loss to minimize unnecessary exposure to risks and unnecessary expenses. Gelesis Loss Of Weight (GLOW; NCT02307279), a multicenter, double-blind, placebo-controlled pivotal study, demonstrated that Gelesis100 offers a compelling new potential approach in the management of overweight and obesity.Objective: A post-hoc area under the curve (AUC) for the receiver op...